US to regulate OTC derivatives
US Treasury secretary reveals plan to supervise over-the-counter derivatives
WASHINGTON, DC - US Treasury secretary Timothy Geithner has this week unveiled plans to regulate the over-the-counter derivatives market in the US.
The move by the Obama administration is in line with steps taken by the European Commission to supervise such trades by forcing them through regulated central counterparties.
The OTC market - estimated to be worth more than $680 trillion - has received bad press throughout the global financial crisis for its opacity, with trades often taking place over the phone, making oversight difficult.
"This is enormously important," said Geithner. "We need better, broader authority, better information, and we need a better commitment of supervisory authorities to enforce those laws."
Channelling 'standardised' OTC derivatives through central clearing houses would reduce the risk of investors being dangerously exposed to a single counterparty in the case of default.
The plan envisages requiring central clearers to produce publicly available data on trading volumes, and to show regulators the trades of individual counterparties.
The new laws could cause increases in bank regulatory capital, as well as providing oversight for a large part of the credit default swap market - products partially blamed for the collapse and federal bail-out of insurance giant AIG.
Geithner said that while "non-standardised" OTC derivatives would remain off the radar under the changes, their popularity had markedly declined recently, and the dealers and firms in those markets with large exposures to them would in any case become subject to tightened regulation.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net
More on Regulation
Esma denies need for new competitiveness mandate
MEP wants explicit requirement; Esma official says it’s already covered in existing rulebook
US regulators cut FRTB’s IMA capital hit by 59%, Isda finds
Trade body pushes for further changes to cross-product netting, default risk charge
US FRTB glitch could spit out negative capital charges
Effort to recognise risk diversification between IMA and standardised approach went too far
Euronext, LCH back Esma as exchange super-regulator
National oversight hurts Europe, exchange officials say – but some are not ready to accept a single watchdog
Double, but no trouble? CVA capital hit may lack clout
Industry opinion mixed around Basel III endgame derivatives charge
Amid debanking drama, banks try to say ‘no’, safely
A basic risk management tool – the ability to turn a customer away – has become a political football
Erba myth: will US banks choose new capital measure?
B3E gives US banks a dilemma – adopt expanded risk-based approach, or a new standardised alternative
Illiquid assets pricing still needs expert judgement, say banks
EU regulators want more transparency in valuations, but some asset prices remain elusive